Effect of patient-reported outcomes as a dialogue-based tool in cancer consultations on patient self-management and health-related quality of life: a clinical, controlled trial

References

• Pasquali S, Hadjinicolaou AV, Chiarion Sileni V, et al. Systemic treatments for metastatic cutaneous melanoma. Cochr Database Syst Rev. 2018;2:CD011123.
   PubMed Web of Science ®Google Scholar
• Michielin O, van Akkooi ACJ, Ascierto PA, et al. Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019;30(12):1884–1901.
   PubMed Web of Science ®Google Scholar
• Michielin O, Hoeller C. Gaining momentum: new options and opportunities for the treatment of advanced melanoma. Cancer Treat Rev. 2015;41(8):660–670.
   PubMed Web of Science ®Google Scholar
• Weitman ES, Perez M, Thompson JF, et al. Quality of life patient-reported outcomes for locally advanced cutaneous melanoma. Melanoma Res. 2018;28(2):134–142.
   PubMed Web of Science ®Google Scholar
• Cormier JN, Davidson L, Xing Y, et al. Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale. J Support Oncol. 2005;3(2):139–145.
   PubMedGoogle Scholar
• Dunn J, Watson M, Aitken JF, et al. Systematic review of psychosocial outcomes for patients with advanced melanoma. Psychooncology. 2017;26(11):1722–1731.
   PubMed Web of Science ®Google Scholar
• Hibbard JH, Mahoney E, Sonet E. Does patient activation level affect the cancer patient journey? Patient Educ Couns. 2017;100(7):1276–1279.
   PubMed Web of Science ®Google Scholar
• McCorkle R, Ercolano E, Lazenby M, et al. Self-management: enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin. 2011;61(1):50–62.
   PubMed Web of Science ®Google Scholar
• Santana MJ, Feeny D. Framework to assess the effects of using patient-reported outcome measures in chronic care management. Qual Life Res. 2014;23(5):1505–1513.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.
   PubMed Web of Science ®Google Scholar
• Weldring T, Smith SM. Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Serv Insights. 2013;6:61–68.
   PubMedGoogle Scholar
• Kotronoulas G, Kearney N, Maguire R, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014;32(14):1480–1501.
   PubMed Web of Science ®Google Scholar
• Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–565.
   PubMed Web of Science ®Google Scholar
• Detmar SB, Muller MJ, Schornagel JH, et al. Health-related quality-of-life assessments and Patient–Physician communication: a randomized controlled trial. JAMA. 2002;288(23):3027–3034.
   PubMed Web of Science ®Google Scholar
• Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22(4):714–724.
   PubMed Web of Science ®Google Scholar
• Greenhalgh J, Dalkin S, Gooding K, et al. Functionality and feedback: a realist synthesis of the collation, interpretation and utilisation of patient-reported outcome measures data to improve patient care. Southampton (UK) NIHR journals library. Health Serv Deliv Res. 2017;5(2):1–280.
   Google Scholar
• Basch E, Barbera L, Kerrigan CL, et al. Implementation of patient-reported outcomes in routine medical care. Am Soc Clin Oncol Educ Book. 2018;38:122–134.
   PubMedGoogle Scholar
• Chen J, Ou L, Hollis SJ. A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res. 2013;13:211.
   PubMed Web of Science ®Google Scholar
• Valderas JM, Kotzeva A, Espallargues M, et al. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res. 2008;17(2):179–193.
   PubMed Web of Science ®Google Scholar
• Marshall R, Beach MC, Saha S, et al. Patient activation and improved outcomes in HIV-infected patients. J Gen Intern Med. 2013;28(5):668–674.
   PubMed Web of Science ®Google Scholar
• Hibbard JH, Stockard J, Mahoney ER, et al. Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4):1005–1026.
   PubMed Web of Science ®Google Scholar
• Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff. 2013;32(2):207–214.
   PubMed Web of Science ®Google Scholar
• Hibbard JH, Mahoney ER, Stock R, et al. Do increases in patient activation result in improved self-management behaviors? Health Serv Res. 2007;42(4):1443–1463.
   PubMed Web of Science ®Google Scholar
• O’Malley D, Dewan AA, Ohman-Strickland PA, et al. Determinants of patient activation in a community sample of breast and prostate cancer survivors. Psycho-oncology. 2018;27(1):132–140.
   PubMed Web of Science ®Google Scholar
• Skovlund PC, Nielsen BK, Thaysen HV, et al. The impact of patient involvement in research: a case study of the planning, conduct and dissemination of a clinical, controlled trial. Res Involv Engagem. 2020;6:43.
   PubMedGoogle Scholar
• Hjollund NHI. Fifteen years’ use of patient-reported outcome measures at the group and patient levels: trend analysis. J Med Internet Res. 2019;21(9):e15856.
   PubMed Web of Science ®Google Scholar
• Skovlund PC, Ravn S, Seibaek L, et al. The development of PROmunication: a training-tool for clinicians using patient-reported outcomes to promote patient-centred communication in clinical cancer settings. J Patient Rep Outcomes. 2020;4(1):10.
   PubMedGoogle Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376.
   PubMed Web of Science ®Google Scholar
• Groenvold M, Klee MC, Sprangers MAG, et al. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol. 1997;50(4):441–450.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370.
   PubMed Web of Science ®Google Scholar
• Bjelland I, Dahl AA, Haug TT, et al. The validity of the hospital anxiety and depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77.
   PubMed Web of Science ®Google Scholar
• Howell D, Molloy S, Wilkinson K, et al. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol. 2015;26(9):1846–1858.
   PubMed Web of Science ®Google Scholar
• Hibbard JH, Mahoney ER, Stockard J, et al. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005;40(6):1918–1930.
   PubMed Web of Science ®Google Scholar
• Maindal HT, Sokolowski I, Vedsted P. Translation, adaptation and validation of the American short form patient activation measure (PAM13) in a Danish version. BMC Public Health. 2009;9(1):209.
   PubMed Web of Science ®Google Scholar
• NHS [Internet]. Patient activation and PAM FAQs England. London (UK): NHS; 2020 [cited 2020 October 30]. Available from https://www.england.nhs.uk/personalisedcare/supported-self-management/patient-activation/pa-faqs/#Q1
   Google Scholar
• Altshuler L, Plaksin J, Zabar S, et al. Transforming the patient role to achieve better outcomes through a patient empowerment program: a randomized wait-list control trial protocol. JMIR Res Protoc. 2016;5(2):e68.
   PubMed Web of Science ®Google Scholar
• National Quality Forum [Internet]. Gains in patient activation (PAM) scores at 12 months. Washington, DC: National Quality Forum; 2016 [cited 2020 November 25]. Available from: http://www.qualityforum.org
   Google Scholar
• Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–579.
   PubMed Web of Science ®Google Scholar
• Cormier JN, Ross MI, Gershenwald JE, et al. Prospective assessment of the reliability, validity, and sensitivity to change of the functional assessment of cancer therapy-melanoma questionnaire. Cancer. 2008;112(10):2249–2257.
   PubMed Web of Science ®Google Scholar
• Askew RL, Xing Y, Palmer JL, et al. Evaluating minimal important differences for the FACT-Melanoma quality of life questionnaire. Value Health. 2009;12(8):1144–1150.
   PubMed Web of Science ®Google Scholar
• Heitzmann CA, Merluzzi TV, Jean-Pierre P, et al. Assessing self-efficacy for coping with cancer: development and psychometric analysis of the brief version of the cancer behavior inventory (CBI-B). Psychooncology. 2011;20(3):302–312.
   PubMed Web of Science ®Google Scholar
• Warrington L. Routine self-reporting of symptoms and side effects during cancer treatment: The patient’s perspective [PhD thesis]. Leeds (UK): University of Leeds; 2018.
   Google Scholar
• Maly RC, Frank JC, Marshall GN, et al. Perceived efficacy in Patient–Physician interactions (PEPPI): validation of an instrument in older persons. J Am Geriatr Soc. 1998;46(7):889–894.
   PubMed Web of Science ®Google Scholar
• Greene J, Hibbard JH, Sacks R, et al. When patient activation levels change, health outcomes and costs change, too. Health Aff. 2015;34(3):431–437.
   PubMed Web of Science ®Google Scholar
• van der Hout A, van Uden-Kraan CF, Holtmaat K, et al. Role of eHealth application oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial. Lancet Oncol. 2020;21(1):80–94.
   PubMed Web of Science ®Google Scholar
• Salgado TM, Mackler E, Severson JA, et al. The relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics: a pilot study with Michigan oncology practices. Support Care Cancer. 2017;25(6):1797–1807.
   PubMed Web of Science ®Google Scholar
• Bos-Touwen I, Schuurmans M, Monninkhof EM, et al. Patient and disease characteristics associated with activation for self-management in patients with diabetes, chronic obstructive pulmonary disease, chronic heart failure and chronic renal disease: a cross-sectional survey study. PLoS One. 2015;10(5):e0126400.
   PubMed Web of Science ®Google Scholar
• Whitman ED, Liu FX, Cao X, et al. Treatment patterns and outcomes for patients with advanced melanoma in US oncology clinical practices. Future Oncol. 2019;15(5):459–471.
   PubMed Web of Science ®Google Scholar
• Kasparian NA, McLoone JK, Butow PN. Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol. 2009;145(12):1415–1427.
   PubMedGoogle Scholar
• Warrington L, Absolom K, Conner M, et al. Electronic systems for patients to report and manage side effects of cancer treatment: systematic review. J Med Internet Res. 2019;21(1):e10875.
   PubMed Web of Science ®Google Scholar
• Howell D, Harth T, Brown J, et al. Self-management education interventions for patients with cancer: a systematic review. Support Care Cancer. 2017;25(4):1323–1355.
   PubMed Web of Science ®Google Scholar
• Fridriksdottir N, Gunnarsdottir S, Zoëga S, et al. Effects of web-based interventions on cancer patients’ symptoms: review of randomized trials. Support Care Cancer. 2018;26(2):337–351.
   PubMed Web of Science ®Google Scholar
• Van Bulck L, Claes K, Dierickx K, et al. Patient and treatment characteristics associated with patient activation in patients undergoing hemodialysis: a cross-sectional study. BMC Nephrol. 2018;19(1):126.
   PubMed Web of Science ®Google Scholar
• Hendriks SH, Hartog LC, Groenier KH, et al. Patient activation in type 2 diabetes: does it differ between men and women? J Diabetes Res. 2016;2016:1–8.
   Web of Science ®Google Scholar
• Laghousi D, Jafari E, Nikbakht H, et al. Gender differences in health-related quality of life among patients with colorectal cancer. J Gastrointest Oncol. 2019;10(3):453–461.
   PubMed Web of Science ®Google Scholar
• Page BR, Guo Y, Han P, et al. Quality of life differences in male and female patients with head and neck cancer. Int J Radiation Oncol Biol Phys. 2018;102(3):e741.
   Web of Science ®Google Scholar
• Basch E, Wood WA, Schrag D, et al. Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial. Clin Trials. 2016;13(3):331–337.
   PubMed Web of Science ®Google Scholar
• Girgis A, Durcinoska I, Levesque JV, et al. eHealth system for collecting and utilizing patient reported outcome measures for personalized treatment and care (PROMPT-Care) among cancer patients: mixed methods approach to evaluate feasibility and Acceptability. J Med Internet Res. 2017;19(10):e330.
   PubMed Web of Science ®Google Scholar
• Basch E, Stover AM, Schrag D, et al. Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT Trial. JCO Clin Cancer Inform. 2020;4:947–957.
   PubMed Web of Science ®Google Scholar
• Taarnhøj GA, Lindberg H, Dohn LH, et al. Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study. Health Qual Life Outcomes. 2020;18(1):225.
   PubMed Web of Science ®Google Scholar